
zzso refers to a large clinically and zzso zzso disease entity associated with slowly progressive zzso loss in different anatomical and functional systems of the zzso zzso diseases often affect zzso zzso Alzheimer's disease zzso zzso with zzso bodies and vascular zzso or different aspects of the motor system, zzso zzso lateral zzso Parkinson's disease and zzso zzso zzso to increasing knowledge about the mechanisms leading to zzso the development of treatments able to modify the neurodegenerative process becomes possible for the first zzso Currently, clinical outcome measures are used to assess the efficacy of such zzso However, most clinical outcome measures have a low zzso reliability and thus considerable measurement zzso zzso large patient populations and long observation times are needed to detect treatment zzso Furthermore, clinical outcome measures cannot distinguish between symptomatic and zzso treatment zzso zzso alternative zzso including zzso may take on a more important role in this zzso Because MR scanners are widely available and allow for zzso detection and zzso of changes in brain structure and zzso there is increasing interest in the use of zzso to monitor zzso treatment effects in clinical trials of neurodegenerative zzso Particularly zzso zzso has been used to measure zzso rates in treatment trials of zzso because the relationship between zzso changes and zzso loss is well established and zzso well with clinical zzso More research is needed to determine the value of other MR zzso zzso zzso zzso and functional zzso and MR zzso for clinical trials with zzso zzso 

